LCTX - Lineage Cell Therapeutics Inc Options

Upgrade to Finviz Elite: Get our fastest platform speed, real-time data, and unlimited screening & charting. Start Free Trial

Peers: EDIT RGNX BEAM NTLA CRSP BMRN INCY KRYS RYTM AXSM

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-0.29	Insider Own	24.81%	Shs Outstand	249.30M	Perf Week	5.79%
Market Cap	319.10M	Forward P/E	-	EPS next Y	-0.09	Insider Trans	0.02%	Shs Float	187.45M	Perf Month	-1.54%
Enterprise Value	266.93M	PEG	-	EPS next Q	-0.02	Inst Own	25.08%	Short Float	13.63%	Perf Quarter	-16.34%
Income	-64.21M	P/S	21.59	EPS this Y	75.51%	Inst Trans	6.72%	Short Ratio	21.65	Perf Half Y	-22.89%
Sales	14.78M	P/B	5.92	EPS next Y	-33.33%	ROA	-58.03%	Short Interest	25.56M	Perf YTD	-23.35%
Book/sh	0.22	P/C	5.98	EPS next 5Y	-	ROE	-96.62%	52W High	2.09 -38.76%	Perf Year	32.74%
Cash/sh	0.21	P/FCF	-	EPS past 3/5Y	-21.30% -14.94%	ROIC	-115.89%	52W Low	0.85 50.59%	Perf 3Y	-5.19%
Dividend Est.	-	EV/EBITDA	-	Sales past 3/5Y	-0.33% 79.88%	Gross Margin	94.36%	Volatility	5.27% 5.33%	Perf 5Y	-54.93%
Dividend TTM	-	EV/Sales	18.06	EPS Y/Y TTM	-250.94%	Oper. Margin	-154.73%	ATR (14)	0.07	Perf 10Y	-28.11%
Dividend Ex-Date	-	Quick Ratio	6.89	Sales Y/Y TTM	54.64%	Profit Margin	-434.44%	RSI (14)	50.95	Recom	1.43
Dividend Gr. 3/5Y	- -	Current Ratio	6.89	EPS Q/Q	-49.18%	SMA20	3.35%	Beta	1.52	Target Price	5.50
Payout	-	Debt/Eq	0.04	Sales Q/Q	14.85%	SMA50	-5.27%	Rel Volume	19.09	Prev Close	1.22
Employees	77	LT Debt/Eq	0.03	Earnings	May 12 AMC	SMA200	-19.81%	Avg Volume	1.18M	Price	1.28
IPO	Mar 05, 1992	Option/Short	Yes / Yes	EPS/Sales Surpr.	-50.00% -52.10%	Trades		Volume	22,531,974	Change	4.92%

Affiliate • Advertise • Careers • Contact • Blog • Help • Privacy • Follow us on X • Do Not Sell My Personal Information

Quotes delayed 15 minutes for NASDAQ, NYSE and AMEX.
Copyright © 2007-2026 Finviz.com. All Rights Reserved. Export All Screener Data (CSV)